Syncom Formulations (India) Limited – NSE:SYNCOMF.NS
Syncom Formulations (India) Limited stock price today
Syncom Formulations (India) Limited stock price monthly change
Syncom Formulations (India) Limited stock price quarterly change
Syncom Formulations (India) Limited stock price yearly change
Syncom Formulations (India) Limited key metrics
Market Cap | 18.95B |
Enterprise value | 6.91B |
P/E | 40.31 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 2.76 |
Price/Book | 2.50 |
PEG ratio | -1.11 |
EPS | 0.29 |
Revenue | 2.63B |
EBITDA | 355.19M |
Income | 253.14M |
Revenue Q/Q | 22.29% |
Revenue Y/Y | 17.45% |
Profit margin | 7.45% |
Oper. margin | 5.89% |
Gross margin | 32.75% |
EBIT margin | 5.89% |
EBITDA margin | 13.49% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSyncom Formulations (India) Limited stock price history
Syncom Formulations (India) Limited stock forecast
Syncom Formulations (India) Limited financial statements
| Jun 2023 | 598.35M | 43.96M | 7.35% |
|---|---|---|---|
| Sep 2023 | 638.38M | 65.11M | 10.2% |
| Dec 2023 | 651.39M | 70.01M | 10.75% |
| Mar 2024 | 745.72M | 74.04M | 9.93% |
| Payout ratio | 0% |
|---|
| 2016 | 0.25% |
|---|---|
| 2017 | 0.25% |
| 2019 | |
| 2020 | |
| 2022 |
| Jun 2023 | 0 | 0 | |
|---|---|---|---|
| Sep 2023 | 4036926000 | 1.33B | 33.08% |
| Dec 2023 | 0 | 0 | |
| Mar 2024 | 4046639000 | 1.16B | 28.79% |
| Jun 2023 | 22M | 0 | 0 |
|---|---|---|---|
| Sep 2023 | 17.57M | 0 | 0 |
| Dec 2023 | 28.91M | 0 | 0 |
| Mar 2024 | 0 | 0 | 0 |
Syncom Formulations (India) Limited alternative data
| Aug 2023 | 754 |
|---|---|
| Sep 2023 | 754 |
| Oct 2023 | 754 |
| Nov 2023 | 754 |
| Dec 2023 | 555 |
| Jan 2024 | 555 |
| Feb 2024 | 555 |
| Mar 2024 | 555 |
| Apr 2024 | 555 |
| May 2024 | 555 |
| Jun 2024 | 555 |
| Jul 2024 | 555 |
Syncom Formulations (India) Limited other data
-
What's the price of Syncom Formulations (India) Limited stock today?
One share of Syncom Formulations (India) Limited stock can currently be purchased for approximately $8.25.
-
When is Syncom Formulations (India) Limited's next earnings date?
Unfortunately, Syncom Formulations (India) Limited's (SYNCOMF.NS) next earnings date is currently unknown.
-
Does Syncom Formulations (India) Limited pay dividends?
No, Syncom Formulations (India) Limited does not pay dividends.
-
How much money does Syncom Formulations (India) Limited make?
Syncom Formulations (India) Limited has a market capitalization of 18.95B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 19.02% to 2.59B US dollars.
-
What is Syncom Formulations (India) Limited's stock symbol?
Syncom Formulations (India) Limited is traded on the NSE under the ticker symbol "SYNCOMF.NS".
-
What is Syncom Formulations (India) Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Syncom Formulations (India) Limited?
Shares of Syncom Formulations (India) Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Syncom Formulations (India) Limited have?
As Jul 2024, Syncom Formulations (India) Limited employs 555 workers.
-
When Syncom Formulations (India) Limited went public?
Syncom Formulations (India) Limited is publicly traded company for more then 2 years since IPO on 18 Nov 2022.
-
What is Syncom Formulations (India) Limited's official website?
The official website for Syncom Formulations (India) Limited is syncomformulations.com.
-
How can i contact Syncom Formulations (India) Limited?
Syncom Formulations (India) Limited can be reached via phone at +91 731 256 0458.
Syncom Formulations (India) Limited company profile:
Syncom Formulations (India) Limited
syncomformulations.comNSE
998
Drug Manufacturers - Specialty & Generic
Healthcare
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It offers various products, including generics, alpha adrenoceptor agonists, analgesics, antipyretics, anti-inflammatory, anti-ulcer agents, antibiotics, antidepressants, antifungals, antihistamines, antimalarial, antiplatelet agents, antiprotozoal, antivirals, bronchodilators, calcium antagonists, cardiac medicines, central nervous stimulants, cephelo sporins, cortico steroids, estrogen, cough suppressants, erectile dysfunction, and electrolite. The company also provides histamines, homeostatic, hypoglycemic, hypolipidaemics, local anesthetics, multivitamins and nutritional supplements, sedative anticonvulsants, stimulants, and sympathomimetic products, as well as products used in the treatment of gout. In addition, it engages in the trading of commodities and renting of properties. Further, the company exports its products. It offers its pharmaceutical formulations products in various dosage forms, such as tablets, capsules, liquids orals, liquid vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and herbals. Syncom Formulations (India) Limited was founded in 1985 and is based in Indore, India.
Indore, 452018
:
ISIN: INE312C01025
:
